• 1
    Williams TJ. The eosinophil enigma. J Clin Invest 2004;113: 507509.
  • 2
    Munitz A, Levi-Schaffer F. Eosinophils: ‘new’ roles for ‘old’ cells. Allergy 2004;59: 268275.
  • 3
    Lampinen M, Carlson M, Håkansson LD, Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004;59: 793805.
  • 4
    Shindo K, Koide K, Fukumura M. PAF-induced eosinophil chemotaxis increases during an asthma attack and is inhibited by prednisolole in vivo and in vitro. Biochem Biophys Res Commun 1997;237: 146151.
  • 5
    Dent G, Hadjicharalambous C, Yoshikawa T, Handy RLC, Powell J, Anderson IK et al. Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum. Am J Respir Crit Care Med 2004;169: 11101117.
  • 6
    Miike S, Kurasawa K, Saito Y, Iwamoto I. Platelet-activating factor activates mitogen-activated protein kinases through the activation of phosphatidylinositol 3-kinase and tyrosine kinase in human eosinophils. J Leukoc Biol 2000;67: 117126.
  • 7
    Boehme SA, Sullivan SK, Crowe PD, Santos M, Conlon PJ, Sriramarao P et al. Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J Immunol 1999;163: 16111618.
  • 8
    Kampen GT, Stafford S, Adachi T, Jinquan T, Quan S, Grant JA et al. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood 2000;95: 19111917.
  • 9
    Kato M, Kimura H, Motegi Y, Tachibana A, Minakami H, Morikawa A et al. Platelet-activating factor activates two distinct effector pathways in human eosinophils. J Immunol 2002;169: 52525259.
  • 10
    Curnock AP, Logan MK, Ward SG. Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases. Immunology 2002;105: 125136.
  • 11
    Taylor ML, Dastych J, Sehgal D, Sundstrom M, Nilsson G, Akin C et al. The Kit-activating mutation D816V enhances stem cell factor-dependent chemotaxis. Blood 2001;98: 11951199.
  • 12
    Dent G, Muñoz NM, Rühlmann E, Zhu X, Leff AR, Magnussen H et al. Protein kinase C inhibition enhances platelet activating factor-induced eicosanoid production in human eosinophils. Am J Respir Cell Mol Biol 1998;18: 136144.
  • 13
    Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 2000;287: 10491053.
  • 14
    Ma AD, Metjian A, Bagrodia S, Taylor S, Abrams CS. Cytoskeletal reorganization by G protein-coupled receptors is dependent on phosphoinositide 3-kinase, a Rac guanosine exchange factor, and Rac. Mol Cell Biol 1998;18: 47444751.
  • 15
    Li Z, Jiang H, Xie W, Zhang Z, Smrcka AV, Wu D. Roles of PLC-β2 and -β3 and PI3Kγ in chemoattractant-mediated signal transduction. Science 2000;287: 10461049.
  • 16
    Takizawa T, Kato M, Kimura H, Suzuki M, Tachibana A, Obinata H et al. Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor. J Allergy Clin Immunol 2002;110: 241248.
  • 17
    Bach MK, Brashler JR, Petzold EN, Sanders ME. Superoxide production by human eosinophils can be inhibited in an agonist-selective manner. Agents Actions 1992;35: 111.
  • 18
    Heit B, Tavener S, Raharjo E, Kubes P. An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients. J Cell Biol 2002;159: 91102.
  • 19
    Tenscher K, Metzner B, Schopf E, Norgauer J, Czech W. Recombinant human eotaxin induces oxygen radical production, Ca2+-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein. Blood 1996;88: 31953199.
  • 20
    Bandeira-Melo C, Phoofolo M, Weller PF. Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J Biol Chem 2001;276: 2277922787.